Longer Treatment with Puberty-Delaying Medication in Transgender Youth Leads to Lower Bone Mineral Density
Endocrine SocietyA longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.